Abstract-Angiotensin II regulates vascular structure through growth and apoptosis, with implications in pathophysiology.
V ascular smooth muscle cells (VSMCs) maintain vascular tone mainly through coordinated contraction/relaxation, and they play a role in arterial wall remodeling through proliferation, hypertrophy, and apoptosis. 1 The arterial tree exhibits heterogeneity in response to vasoactive stimuli and in alterations induced by hypertension or atherosclerosis. The concept that distinct VSMC subtypes may play specific roles, at different locations or pathophysiological situations, is well documented in animals, [2] [3] [4] [5] [6] and VSMC heterogeneity also exists in human arteries. 7 In the rat arterial model, 2 major VSMC subtypes have been discerned on the basis of stable distinct morphologies in culture: spindle versus epithelioid. 2, 8, 9 They also differ in growth properties or protein synthesis 2,8 -11 ; however, their responses to vasoactive stimuli are barely known. 12 Angiotensin (Ang) II, the main effector peptide of the renin-angiotensin system, plays an important role in normal vascular physiology and cardiovascular diseases, 13 mostly through the Ang II type 1 (AT 1 ) receptor and partly through the Ang II type 2 (AT 2 ) receptor. AT 1 receptor-mediated intracellular calcium concentration ([Ca 2ϩ ] i ) signaling is a major determinant of VSMC contraction. 14 Ang II is a modulator of VSMC growth with proliferative/hypertrophic effects mediated by the AT 1 receptor through complex, partly calcium-dependent, signaling. 14 Heterogeneity exists in Ang II calcium signaling 14 -16 and long-term responses [17] [18] [19] between individual VSMCs, arteries, or arterial layers. In vivo, Ang II can induce a delayed apoptosis through AT 1 receptor activation. 20, 21 Inversely, in vitro, Ang II induces apoptosis through AT 2 receptor activation in AT 2 -transfected VSMCs, 22 whereas AT 1 receptors might also protect native VSMCs against acute NO-induced apoptosis. 23 The question of whether the diversity in Ang II biological effects could originate from variations in the different VSMC subtypes has not been addressed. Therefore, the aim of the present study was to investigate whether VSMC subtypes responded differently to Ang II in [Ca 2ϩ ] i signaling and long-term survival. We used 2 stable cell lines, Sp-SMC and Ep-SMC, as respective models of spindle and epithelioid rat arterial VSMC subtypes. The results show dramatically different Ang II responses in the 2 VSMC lines. A delayed AT 1 receptor-mediated calcium-dependent apoptosis was elicited in Ep-SMCs only; it was related to specific calcium signaling. This strongly suggests a phenotype-dependent apoptotic sensitivity of VSMCs to Ang II through AT 1 receptors.
Methods

Materials
Ang II, nifedipine, N G nitro-L-arginine methyl ester (L-NAME), thapsigargin (TG), and propidium iodide (Sigma Chemical Co), EXP3174 (active metabolite of losartan), PD 123,177, and DUP753 (losartan) (Merck Sharp & Dohme), nisoldipine (Bayer), CGP42112A (RBI), fura 2-AM and SYTO-16 (Molecular Probes), polyclonal anti-AT 1 and anti-AT 2 antibodies (Santa Cruz), monoclonal anti-myosin (smooth) and anti-␣-actin (Sigma), and annexin V-FITC (Immunotech) were used.
SMC Cultures
Sp-SMCs and Ep-SMCs, initially named V6-SMCs and V8-SMCs, respectively, have been isolated from Wistar rat aortic media as stable cell lines. 8 Standard primary VSMCs from rat aorta, 24 
Viability
Whole viability of a culture was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test 26 or by counting cell number (Coulter counter, Coultronics). 24 
Morphology of Apoptosis or Necrosis
For nuclear staining, monolayers were coincubated with 1 g/mL SYTO-16 and 4 g/mL propidium iodide fluorescent DNA-binding dyes. 26 Dead cells, permeable for propidium iodide, stained red. Apoptosis (green condensed or fragmented nuclei), primary necrosis (red nuclei with loose chromatin), postapoptotic necrosis (red apoptotic nuclei), and normal cells (green nuclei with loose chromatin) were discriminated.
Annexin V-FITC Staining
Trypsinized VSMCs washed in binding buffer were incubated in FITC-labeled annexin V (annexin kit, Immunotech) for 10 minutes. Cells were analyzed by flow cytometry by using a single cell gate, and the percentage of annexin-positive cells was evaluated.
DNA Fragmentation
DNA fragmentation was visualized by the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) procedure (In Situ Cell Death Detection POD kit, Boehringer). For quantification of DNA fragmentation, cell lysates were centrifuged (27 000g). Separated chromatin pellet and DNA cleavage products were quantified by the fluorometric 4,6-diamidino-2-phenylindole procedure. 26 DNA ladders were visualized by ethidium bromide after DNA electrophoresis (Suicide-Track DNA Ladder Isolation Kit, Oncogene Research Products).
Caspase 3-Like Activity
Caspase 3-like activity was determined by detecting chromophore p-nitroanilide after cleavage from the labeled substrate ac-DEVD-pnitroanilide (Bachem).
Immunofluorescence Microscopy
Cells on coverslips, fixed with methanol, were incubated with primary antibody (1:50 dilution) and then with the appropriate fluorescein-conjugated secondary antibody. 8 
Western Blot Analysis
Proteins (40 g) were subjected to SDS-PAGE, transferred to membranes (Amersham), incubated with primary antibody (1:200 dilution) and the appropriate secondary antibody, 26 and visualized by ECL kit (Amersham).
Data Analysis
Values are presented as meanϮSEM. Groups were compared by ANOVA, and means were compared by the Student's t test. Values of PϽ0.05 were considered statistically significant.
Results
VSMC Phenotypes
The stable morphologically distinct Sp-SMC and Ep-SMC cell lines ( Figure 1A ) expressed both smooth muscle ␣-actin (43 kDa) and myosin heavy chain (205 kDa) under low serum conditions (0.2%), but expression was markedly lower in Ep-SMCs ( Figure 1B ). Only Ep-SMCs were capable of serum-independent growth ( Figure 1C ), as were other epithelioid smooth muscle cell models. 9,10 AT 1 receptor (41 kDa) expression was higher in Ep-SMCs. AT 2 receptor (44 kDa) expression was comparable between both cell lines ( Figure 1B ). 
Ang II-Stimulated [Ca 2؉ ] i Signaling in VSMC Phenotypes
In VSMC cultures, Ang II elicited a classic biphasic [Ca 2ϩ ] i signal with a transient peak, followed by a stationary phase slightly above the baseline (Figure 2A ). In Sp-SMCs, the response was a single transient peak. In Ep-SMCs, the signal was biphasic, with a high plateau. The basal [Ca 2ϩ ] i and plateau levels were higher in Ep-SMCs ( Figure 2B ). All responses were dose dependent ( Figure 2C 
Calcium Sources of Ang II-Induced [Ca 2؉ ] i Signaling in VSMC Phenotypes
In calcium-free medium, the peak responses to Ang II were similar in Sp-SMCs and Ep-SMCs, whereas the plateau phase was abolished in Ep-SMCs ( Figure 2D ). This suggests that the Ang II-induced transient [Ca 2ϩ ] i peak resulted mainly from internal calcium stores, whereas the plateau in Ep-SMCs required calcium entry. Pretreatment with TG (1.5 mol/L, 7 minutes before Ang II), an inhibitor of the sarcoplasmic reticulum calcium-ATPase pump, increased [Ca 2ϩ ] i by depletion of TG-sensitive stores. In both lines, TG prevented, in calcium-free medium, a subsequent Ang II-induced signal ( Figure 2D ). This suggests no difference in the intracellular pools (TG sensitive) rapidly mobilized by Ang II in the 2 phenotypes. Preincubation with nifedipine (10 mol/L, dihydropyridine blocker of L-type voltage-operated channels) did not alter the Sp-SMC response but reduced the peak and abolished the plateau in Ep-SMCs ( Figure 2E) . NiCl 2 (100 mol/L) abolished the Ep-SMC response, suggesting the participation of calcium-induced calcium release. 27 In summary, in both Sp-SMCs and Ep-SMCs, calcium was rapidly mobilized by Ang II from TG-sensitive intracellular pools. In Ep-SMCs, an additional calcium entry occurred, mostly through L-type voltage-operated channels.
Ang II-Induced VSMC PhenotypeDependent Apoptosis
Under low serum conditions (0.2%), Ang II dramatically reduced Ep-SMC but not Sp-SMC number ( Figure 3A) , suggesting that Ang II differently altered cell survival. Reduction in Ep-SMC number was dose dependent ( Figure  3B ) and occurred 3 days after stimulation (not shown). At 10 minutes, Ang II incubation was enough to reduce the cell number 3 days later ( Figure 3B ). The nature of cell death was characterized. Examination of Ep-SMC morphology showed that Ang II promoted apoptosis, ie, nuclear condensation, apoptotic bodies, chromatin fragmentation, and postapoptotic necrosis ( Figure 4C ; 40Ϯ18% apoptotic figures in Ang II-treated Ep-SMCs versus 8Ϯ3% apoptotic figures in control Ep-SMCs, PϽ0.05). Primary necrosis was Ͻ5% of nuclei. Apoptosis was confirmed by TUNEL staining ( Figure  4D and 4E), DNA ladders ( Figure 5A ), DNA fragmentation ( Figure 5B ; 33Ϯ5.8% in Ep-SMCs versus 7Ϯ5.6% in controls, PϽ0.05), and caspase 3-like activity ( Figure 5C ). Interestingly, opposite effects were induced in Sp-SMCs ( Figure 5B and 5C ). Kinetics of annexin V-FITC labeling to exposed plasma membrane phosphatidylserine (early apoptosis marker) showed that Ang II promoted not an early (up to 24 to 36 hours) but a delayed increase in the labeled Ep-SMC population ( Figure 5D and 5E). Taken together, the results show that Ang II promoted a delayed apoptosis in Ep-SMCs but not in Sp-SMCs.
AT 1 -Receptor-Induced and Calcium-Dependent Apoptosis in Ep-SMCs
Apoptosis was abolished by AT 1 (EXP3174) but not by AT 2 (PD 123,177) receptor antagonists ( Figure 6A , 6B, and 6C) 
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and was not induced by the AT 2 agonist CGP42112A (not shown). We tested whether NO, a known inducer of VSMC apoptosis, could mediate apoptosis. L-NAME (10 mol/L), an inhibitor of NO generation, did not prevent Ang IIinduced Ep-SMC death ( Figure 6A ). Because Ang II specifically induced calcium entry in Ep-SMCs, we studied whether calcium entry was involved in apoptosis. Ang II-induced Ep-SMC apoptosis was significantly inhibited by EGTA (5 mmol/L, 20 minutes; Figure 6A and 6C), nifedipine (10 mol/L, Figure 6A ), or nisoldipine (10 mol/L, Figure 6B and 6C). Conversely, A23187 (10 mol/L, 20 minutes), a calcium ionophore, induced Ep-SMC death ( Figure 6A ). The results demonstrate that Ang II-induced apoptosis in EpSMCs involved calcium entry and was mediated by AT 1 receptors but not by AT 2 receptors.
Discussion
The present study shows for the first time that Ang II can induce apoptosis in VSMCs depending on their phenotype (epithelioid or spindle-shaped) through the activation of AT 1 receptor-mediated calcium entry. Apoptosis was specifically promoted in the epithelioid phenotype (Ep-SMCs). Characterization of cell death was made on the basis of typical morphological features (cell shrinkage, nuclear condensation, and fragmentation) and biochemical changes (DNA fragmentation, caspase 3-like activity, and annexin V binding after plasma membrane phosphatidylserine translocation). Apoptosis was dose and time dependent and occurred under serum deprivation. Ang II is well known as a regulator of VSMC proliferation/ hypertrophy. More recently, Ang II has been proposed as a bifunctional modulator of VSMC apoptosis through either AT 1 (antiapoptotic) or AT 2 (proapoptotic) receptors. 22 Previous in vitro results have shown that Ang II can induce apoptosis in AT 2 receptor-transfected VSMCs 22 and protect native VSMCs, through AT 1 receptors, against early (NOinduced) apoptosis. 23 In the present study, in VSMCs of different phenotypes, Ang II did not induce early apoptosis as reported in a previous study. 23 However, in Ep-SMCs, Ang II promoted a delayed apoptosis. Consistently, apoptosis has been reported in a delayed manner 20 in rat arteries via the AT 1 receptor. 20, 21 The present AT 1 receptor-induced apoptosis extends the possible cellular mechanisms of VSMC growth regulation by Ang II. Summarizing, AT 1 receptor activation may control VSMC growth through either proliferation or delayed apoptosis, whereas AT 2 receptor activation may induce antigrowth effects (inhibition of proliferation and apoptosis).
The VSMC phenotype specificity in the apoptotic response to Ang II cannot be explained by differential AT 1 /AT 2 receptor expression in Sp-SMCs versus Ep-SMCs. Both cell lines expressed AT 1 and AT 2 receptors, but apoptosis was clearly AT 1 receptor-mediated, inasmuch as it was prevented by AT 1 but not by AT 2 receptor antagonists and was not induced by an AT 2 receptor agonist. Apoptosis in Ep-SMCs required only short Ang II exposure with associated calcium influx. Apoptosis was reduced by an extracellular calcium chelator and by calcium antagonists. Furthermore, apoptosis was induced by a calcium ionophore. Thus, the AT 1 receptormediated calcium entry seems causally involved in apoptosis. A role for calcium signaling is documented in apoptosis 28 and in AT 1 receptor-induced apoptosis. 29, 30 Calcium can directly activate hydrolytic enzymes or signal cell death through calcium-dependent kinases or phosphatases. Further investigation will be necessary to determine precisely the AT 1 receptor downstream apoptotic pathway in Ep-SMCs.
Regional heterogeneity exists in response to vasoactive stimuli in normal and diseased vessels. One hypothesis is that arterial walls vary in composition of different VSMC subtypes to fulfill specific roles. [2] [3] [4] [5] [6] Heterogeneity was mostly studied with VSMC cell lines originating from different rat arteries. 2,8 -11,31 In the present study, VSMC lines of spindle or epithelioid phenotypes, both from healthy adult rat aortas, 8 were used. Similarity in their culture history allowed comparison of the intrinsic properties of the phenotypes, excluding the influence of environmental factors. 10, 11, 31 Although transformed, these cell lines can be compared with other models of VSMC subtypes 9, 10 ; the 2 VSMC lines differ in serum-independent growth (specific to epithelioid cells) and in differentiation state (lower for epithelioid cells) as in other models. 9, 10 In the present study, AT 1 receptors were functional in both phenotypes but were coupled to distinct AT 1 receptor [Ca 2ϩ ] i signals. The sustained calcium entry specific to Ep-SMCs has been observed in epithelioid VSMC-enriched cultures stimulated with other vasoconstrictors, 12 and it could be a feature of the epithelioid subtype. VSMC heterogeneity might participate in regional differences in contractile or pathological alterations. As a major point, the present study suggests a susceptibility of epithelioid VSMCs to Ang II-induced apoptosis. Interestingly, a higher ACE activity (ie, potential Ang II formation) was found in epithelioid compared with elongated embryonic VSMCs. 7 The renin-angiotensin system could be a determinant of VSMC subtypespecific behavior.
VSMC apoptosis occurs in all cardiovascular diseases, hypertension, atherosclerosis, and restenosis. 1 The present Ang II effects on VSMC subtypes could have pathophysiological relevance. An AT 1 receptor-mediated remodeling of vascular wall mass by apoptosis of a peculiar VSMC subtype may occur. This process could regulate proliferation during healing, 19 in aneurisms, in narrowed peripheric arteries, or within atherosclerotic lesions. 1 With respect to atherosclerosis, human plaques contain a VSMC subtype 32 with apoptotic-prone behavior 33 and have increased ACE activity. 34 Therefore, Ang II could locally contribute to plaque weakening and rupture by promoting apoptosis. Finally, the present study points out the importance of extending the knowledge on VSMC heterogeneity to better understand vascular pathology.
